SETD1A, an H3K4 methyltransferase, plays essential roles in multiple types of cancer progression including gastric cancer, colorectal cancer, and breast cancer [18–23], and liver cancer sorafenib resistance [24]. This evidence concerns the gene SETD1A and breast cancer.